Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of...
-
ALEXANDRIA, Va., Nov. 17, 2021 (GLOBE NEWSWIRE) -- HRCI, in partnership with MindEdge Learning, has produced a new series of courses, the Certificate in Diversity and Inclusion in HR Management, to...
-
TUALATIN-PORTLAND, OR, Nov. 16, 2021 (GLOBE NEWSWIRE) -- iGrafx, a worldwide leader in digital business transformation and process management, announces that Abhijit Kakhandiki, business process...
-
JERSEY CITY, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Vision Hydrogen Corporation (OTCQB:VIHD) (the “Company”) announces the completion of the acquisition of VoltH2 Holdings AG...
-
TORONTO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) announces changes to its leadership. Administration Effective immediately, Greg...
-
WASHINGTON, D.C., Nov. 04, 2021 (GLOBE NEWSWIRE) -- MorganFranklin Consulting, a leading management and technology advisory firm that specializes in solving complex transformational challenges for...
-
Feedzai Introduces World’s First RiskOps Platform to solve the Problem of FinCrime Software Overload
Single, comprehensive cloud-based platform to manage multiple forms of risk and compliance with a fully extensible architecture that allows to instantly go from sandbox to productionHuman-Centered AI...
-
Atlanta, Georgia, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Hunton Andrews Kurth LLP is pleased to announce that Douglass P. Selby, partner and co-chair of the firm’s national public finance practice, has...
-
SINGAPORE, Oct. 21, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire) –– Alpha Impact (https://alphaimpact.fi/), a social copy trading platform that features daily insights from expert crypto traders,...
-
Senior leader with extensive global rare disease commercialization experienceTop-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 ...